News Focus
News Focus
Replies to #564 on Biotech Values
icon url

DewDiligence

12/09/03 11:42 AM

#565 RE: isolution #564

My impression is that AVE plans to pursue AMD via REGN’s VEGF-Trap rather than via their in-house VTA.